Brown Ryan Edward (CIK 0001848718)

Latest company ownership

SRPT - Sarepta Therapeutics, Inc.
Role: EVP, General Counsel
Shares held
23,500
Last filed at
Jun 25, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jun 21, 2024 Jun 25, 2024 Sarepta Therapeutics, Inc. EVP, General Counsel Sell 18.8 -41,309 -13.10% ✓ $6.7M
Mar 7, 2024 Mar 11, 2024 Sarepta Therapeutics, Inc. EVP, General Counsel Sell 42.5 -1,405 -4.67% ✗ $171.7K
Mar 4, 2024 Mar 6, 2024 Sarepta Therapeutics, Inc. EVP, General Counsel Sell 42.5 -1,734 -5.45% ✗ $217.3K
Mar 1, 2024 Mar 5, 2024 Sarepta Therapeutics, Inc. EVP, General Counsel Sell 97.5 +3,731 13.28% ✗ $284.6K
Jun 1, 2023 Jun 5, 2023 Sarepta Therapeutics, Inc. EVP, General Counsel Sell 51.3 -89 -0.32% ✗ $11K
Mar 8, 2023 Mar 10, 2023 Sarepta Therapeutics, Inc. SVP, General Counsel Sell 42.5 -635 -2.20% ✗ $97.3K
Mar 6, 2023 Mar 8, 2023 Sarepta Therapeutics, Inc. SVP, General Counsel Sell 95.0 +3,175 12.38% ✗ $208.3K
Mar 1, 2023 Mar 3, 2023 Sarepta Therapeutics, Inc. SVP, General Counsel Sell 48.8 -196 -0.76% ✗ $28.9K
Jun 1, 2022 Jun 3, 2022 Sarepta Therapeutics, Inc. SVP, General Counsel Sell 52.5 -54 -0.21% ✗ $3.9K
Mar 4, 2022 Mar 8, 2022 Sarepta Therapeutics, Inc. SVP, General Counsel Sell 95.0 +6,711 34.98% ✗ $102.1K
Mar 1, 2022 Mar 1, 2022 Sarepta Therapeutics, Inc. SVP, General Counsel Sell 48.8 -184 -0.95% ✗ $13.8K
Jun 1, 2021 Jun 3, 2021 Sarepta Therapeutics, Inc. SVP, General Counsel Sell 52.5 -64 -0.33% ✗ $4.9K
Feb 28, 2021 Mar 10, 2021 Sarepta Therapeutics, Inc. SVP, General Counsel Sell 91.3 +14,594 301.65% ✗ $34.1K